Diabetes Health profiles Echo Therapeutics' Symphony noninvasive glucose monitoring system

Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that its Symphony System was profiled in the November 29, 2010 issue of Diabetes Health magazine.

The article can be found at: http://www.diabeteshealth.com/read/2010/11/29/6962/echo-therapeutics-needle-free-symphony-continuous-glucose-monitoring-system/.

The article discusses the Symphony continuous glucose monitoring system as potentially the first "noninvasive" glucose monitor to successfully come to the market. According to the article, "The need in the market is great right now for both patients and medical professionals to use in their practices and in surgeries. The days of having to use a needle to test blood glucose are numbered, and the need for an effective continuous monitoring system is becoming increasingly essential as the number of patients with diabetes grows."

Diabetes Health has a total circulation of 150,000, including 25,000 digital subscribers, 25,000 paid consumers and a 100,000-member "controlled and qualified Direct-to-Patient Circulation Program." The Direct-to-Patient Circulation Program is requested by and distributed to a controlled and qualified list of certified diabetes educators, physicians and nurses. They in turn give Diabetes Health to 100,000 newly diagnosed patients as an educational tool every two months.

"We are pleased to be recognized and have our innovative Symphony system profiled in Diabetes Health magazine, long recognized as one of the leading authorities on managing diabetes," commented  Patrick T. Mooney, M.D., Chairman, President and CEO of Echo.  "Diabetes authorities are increasingly embracing the need for continuous glucose monitoring as a way to more effectively manage the disease, and Symphony represents the first proven non-invasive method for ensuring continuous monitoring. In addition, Symphony replaces the painful use of a needle to test blood glucose, improving the quality of life for diabetics."